Annual Accounts Payable
$5.63 M
+$442.00 K+8.52%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual accounts payable is $5.63 million, with the most recent change of +$442.00 thousand (+8.52%) on December 31, 2023.
- During the last 3 years, ACHL annual accounts payable has fallen by -$685.00 thousand (-10.85%).
- ACHL annual accounts payable is now -10.85% below its all-time high of $6.31 million, reached on December 31, 2020.
Performance
ACHL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.25 M
+$1.38 M+48.27%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly accounts payable is $4.25 million, with the most recent change of +$1.38 million (+48.27%) on September 1, 2024.
- Over the past year, ACHL quarterly accounts payable has dropped by -$1.38 million (-24.53%).
- ACHL quarterly accounts payable is now -44.47% below its all-time high of $7.65 million, reached on March 31, 2023.
Performance
ACHL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ACHL Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.5% | -24.5% |
| 3 y3 years | -10.8% | -43.5% |
| 5 y5 years | +524.1% | -43.5% |
ACHL Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.2% | -44.5% | +48.3% |
| 5 y | 5-year | -10.8% | +524.1% | -44.5% | +137.7% |
| alltime | all time | -10.8% | +524.1% | -44.5% | +137.7% |
Achilles Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.25 M(+48.3%) |
| Jun 2024 | - | $2.87 M(-13.5%) |
| Mar 2024 | - | $3.31 M(-41.1%) |
| Dec 2023 | $5.63 M(+8.5%) | $5.63 M(+5.2%) |
| Sep 2023 | - | $5.35 M(-22.3%) |
| Jun 2023 | - | $6.89 M(-10.0%) |
| Mar 2023 | - | $7.65 M(+47.5%) |
| Dec 2022 | $5.19 M | $5.19 M(-31.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.52 M(+13.0%) |
| Jun 2022 | - | $6.65 M(+64.8%) |
| Mar 2022 | - | $4.04 M(+8.4%) |
| Dec 2021 | $3.72 M(-41.1%) | $3.72 M(+51.3%) |
| Sep 2021 | - | $2.46 M(-59.4%) |
| Jun 2021 | - | $6.05 M(+238.8%) |
| Mar 2021 | - | $1.79 M(-71.7%) |
| Dec 2020 | $6.31 M(+600.0%) | $6.31 M |
| Dec 2019 | $902.00 K | - |
FAQ
- What is Achilles Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Achilles Therapeutics?
- What is Achilles Therapeutics annual accounts payable year-on-year change?
- What is Achilles Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly accounts payable year-on-year change?
What is Achilles Therapeutics annual accounts payable?
The current annual accounts payable of ACHL is $5.63 M
What is the all time high annual accounts payable for Achilles Therapeutics?
Achilles Therapeutics all-time high annual accounts payable is $6.31 M
What is Achilles Therapeutics annual accounts payable year-on-year change?
Over the past year, ACHL annual accounts payable has changed by +$442.00 K (+8.52%)
What is Achilles Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ACHL is $4.25 M
What is the all time high quarterly accounts payable for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly accounts payable is $7.65 M
What is Achilles Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ACHL quarterly accounts payable has changed by -$1.38 M (-24.53%)